FDCDDQ
BXRX

Federation des caisses Desjardins du Quebec’s Baudax Bio, Inc. Common Stock BXRX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio BXRX Stock Details BXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2
Closed -$1.9K – 2640
2021
Q2 		$1.9K Hold
2
– – ﹤0.01% 2391
2021
Q1 		$3.23K Sell
2
-1
-33% -$2K ﹤0.01% 2281
2020
Q4 		$4.85K Buy
+3
New +$6.14K ﹤0.01% 2086

Other funds holding BXRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's BXRX Position: Q3 2021 in Review

Federation des caisses Desjardins du Quebec sold out of Baudax Bio, Inc. Common Stock (BXRX) in Q3 2021, closing a stake of 2 shares — an estimated $1.9K sold.

Federation des caisses Desjardins du Quebec first reported a position in BXRX in Q4 2020 and held it in 3 quarters. The position peaked at $4.85K in Q4 2020. 26 funds tracked by Wall St. Rank hold BXRX as of Q3 2021.

  • Federation des caisses Desjardins du Quebec reported no remaining Baudax Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 2 Baudax Bio, Inc. Common Stock shares in Q3 2021, an estimated $1.9K.
  • Federation des caisses Desjardins du Quebec first reported a position in Baudax Bio, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Federation des caisses Desjardins du Quebec's Baudax Bio, Inc. Common Stock position peaked at $4.85K in Q4 2020.
  • 26 funds tracked by Wall St. Rank held Baudax Bio, Inc. Common Stock as of Q3 2021.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2021, filed 30 Aug 2024.